Akoya is updating its revenue outlook for the full year 2024 while maintaining its commitment to achieving operating cash flow breakeven by year end. The Company now expects full year 2024 revenue to be in the range of $104.0-$112.0 million.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AKYA:
- AKYA Earnings this Week: How Will it Perform?
- Akoya, NeraCare enter exclusive agreement for personalized therapy selection
- Akoya Biosciences and NeraCare Enter into an Exclusive Agreement to Enable Personalized Therapy Selection for Early-Stage Melanoma Patients
- Akoya Biosciences opens Operations and Manufacturing Center in Marlborough
- Akoya Biosciences Opens Operations and Manufacturing Center of Excellence in Marlborough, Massachusetts